IL141519A0 - A new composition of (r) -3-n, n-dicyclobutylamino-8-fluoro-3, 4-dihydro-3h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate monohydrate and paroxetine - Google Patents
A new composition of (r) -3-n, n-dicyclobutylamino-8-fluoro-3, 4-dihydro-3h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate monohydrate and paroxetineInfo
- Publication number
- IL141519A0 IL141519A0 IL14151999A IL14151999A IL141519A0 IL 141519 A0 IL141519 A0 IL 141519A0 IL 14151999 A IL14151999 A IL 14151999A IL 14151999 A IL14151999 A IL 14151999A IL 141519 A0 IL141519 A0 IL 141519A0
- Authority
- IL
- Israel
- Prior art keywords
- dicyclobutylamino
- paroxetine
- benzopyran
- dihydro
- fluoro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803156A SE9803156D0 (en) | 1998-09-16 | 1998-09-16 | A new composition |
| PCT/SE1999/001597 WO2000015218A1 (en) | 1998-09-16 | 1999-09-13 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141519A0 true IL141519A0 (en) | 2002-03-10 |
Family
ID=20412627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14151999A IL141519A0 (en) | 1998-09-16 | 1999-09-13 | A new composition of (r) -3-n, n-dicyclobutylamino-8-fluoro-3, 4-dihydro-3h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate monohydrate and paroxetine |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1128825A1 (en) |
| JP (1) | JP2002524508A (en) |
| KR (1) | KR20010099647A (en) |
| CN (1) | CN1317964A (en) |
| AR (1) | AR021808A1 (en) |
| AU (1) | AU6378099A (en) |
| BR (1) | BR9913748A (en) |
| CA (1) | CA2342341A1 (en) |
| CZ (1) | CZ2001961A3 (en) |
| EE (1) | EE200100157A (en) |
| HU (1) | HUP0103544A3 (en) |
| ID (1) | ID28785A (en) |
| IL (1) | IL141519A0 (en) |
| IS (1) | IS5879A (en) |
| NO (1) | NO20011312L (en) |
| PL (1) | PL346763A1 (en) |
| SE (1) | SE9803156D0 (en) |
| SK (1) | SK3262001A3 (en) |
| TR (1) | TR200100779T2 (en) |
| WO (1) | WO2000015218A1 (en) |
| ZA (1) | ZA200101946B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2425638C (en) | 2000-10-13 | 2011-04-05 | Neurosearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| WO2006093192A1 (en) * | 2005-03-04 | 2006-09-08 | Tokyo Medical And Dental University | Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (en) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803156A patent/SE9803156D0/en unknown
-
1999
- 1999-09-13 CZ CZ2001961A patent/CZ2001961A3/en unknown
- 1999-09-13 AU AU63780/99A patent/AU6378099A/en not_active Abandoned
- 1999-09-13 PL PL99346763A patent/PL346763A1/en unknown
- 1999-09-13 KR KR1020017003337A patent/KR20010099647A/en not_active Application Discontinuation
- 1999-09-13 IL IL14151999A patent/IL141519A0/en unknown
- 1999-09-13 CN CN99811010A patent/CN1317964A/en active Pending
- 1999-09-13 TR TR2001/00779T patent/TR200100779T2/en unknown
- 1999-09-13 HU HU0103544A patent/HUP0103544A3/en unknown
- 1999-09-13 WO PCT/SE1999/001597 patent/WO2000015218A1/en not_active Application Discontinuation
- 1999-09-13 ID IDW20010581A patent/ID28785A/en unknown
- 1999-09-13 EE EEP200100157A patent/EE200100157A/en unknown
- 1999-09-13 SK SK326-2001A patent/SK3262001A3/en unknown
- 1999-09-13 BR BR9913748-8A patent/BR9913748A/en not_active Application Discontinuation
- 1999-09-13 EP EP99951319A patent/EP1128825A1/en not_active Withdrawn
- 1999-09-13 JP JP2000569802A patent/JP2002524508A/en active Pending
- 1999-09-13 CA CA002342341A patent/CA2342341A1/en not_active Abandoned
- 1999-09-15 AR ARP990104626A patent/AR021808A1/en not_active Application Discontinuation
-
2001
- 2001-03-07 IS IS5879A patent/IS5879A/en unknown
- 2001-03-08 ZA ZA200101946A patent/ZA200101946B/en unknown
- 2001-03-15 NO NO20011312A patent/NO20011312L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200101946B (en) | 2002-06-10 |
| WO2000015218A1 (en) | 2000-03-23 |
| NO20011312D0 (en) | 2001-03-15 |
| HUP0103544A3 (en) | 2003-12-29 |
| EE200100157A (en) | 2002-08-15 |
| PL346763A1 (en) | 2002-02-25 |
| AR021808A1 (en) | 2002-08-07 |
| JP2002524508A (en) | 2002-08-06 |
| HUP0103544A2 (en) | 2002-05-29 |
| NO20011312L (en) | 2001-05-16 |
| ID28785A (en) | 2001-07-05 |
| CZ2001961A3 (en) | 2001-08-15 |
| CN1317964A (en) | 2001-10-17 |
| TR200100779T2 (en) | 2001-10-22 |
| IS5879A (en) | 2001-03-07 |
| KR20010099647A (en) | 2001-11-09 |
| SE9803156D0 (en) | 1998-09-16 |
| BR9913748A (en) | 2001-07-10 |
| AU6378099A (en) | 2000-04-03 |
| EP1128825A1 (en) | 2001-09-05 |
| SK3262001A3 (en) | 2001-08-06 |
| CA2342341A1 (en) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103408A3 (en) | Methods of using and compositions comprising dopamine reuptake inhibitors | |
| PL352014A1 (en) | Dietetic of pharmacological composition for preventing or treating hyperoxaluria | |
| HK1044528A1 (en) | Monoamine reuptake inhibitors for treatment of cnsdisorders. | |
| AU2003301857A1 (en) | New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and | |
| HUP0201728A2 (en) | (s)-enantiomer enriched fipronil composition | |
| IL141519A0 (en) | A new composition of (r) -3-n, n-dicyclobutylamino-8-fluoro-3, 4-dihydro-3h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate monohydrate and paroxetine | |
| IS1943B (en) | (R) -3-N, N-Dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate, its method of manufacture and pharmaceutical compositions containing it | |
| IL141520A0 (en) | A new composition of (r) -3-n,n-dicyclobutylamino- 8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate and 1-c3- (dimethylamino) propyl! -1 (p-fluorophenyl) -5- phthalancarbonitrile | |
| AU1573100A (en) | Composition of paroxetine methanesulfonate | |
| HU9802716D0 (en) | Pharmaceutical composition of analgesic activity | |
| EP1372692A4 (en) | Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor | |
| IL139596A0 (en) | Novel formulation containing paroxetine | |
| HUP0201135A2 (en) | Substituted benzolactam compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| EP1096927A4 (en) | Composition for treatment of stress | |
| IL136590A0 (en) | Process for preparation of paroxetine hydrochloride | |
| HUP0102116A3 (en) | Paroxetine ascorbate, process for its preparation and its pharmaceutical use | |
| TW356669U (en) | Structure for head machine of shoelace | |
| IL139594A0 (en) | Novel formulation containing paroxetine | |
| TW362514U (en) | Improved structure for head of shuttlecock | |
| TW349427U (en) | Secure structure of copper-piece-filled for golf head | |
| AU3147800A (en) | New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine | |
| TW353380U (en) | Improved structure for head of golf | |
| TW348546U (en) | Structure improvement for vibration-reducing block of racket | |
| TW453216U (en) | Improved structure of thread-pulling head for thread-mounting machine of racket | |
| TW362523U (en) | New structure for putter head of golf |